In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Priming Russia’s Pharma Industry For Innovation

Executive Summary

The Russian government’s aggressive plan to modernize the country’s pharmaceutical industry is stimulating entrepreneurial activities, as well as a flurry of deal activity between local and foreign companies. Many uncertainties remain about the potential opportunities, however, as foreign companies try to sort out changing regulatory and business dynamics.

Advertisement

Related Content

Real World Data Solutions For Pharma’s Looming EBIT Crisis
Abbvie: A Glimpse Of What The New Biopharma Will Look Like
To Russia, With Love: Selecta, BIND To Create Subsidiaries In Financing Deals With Rusnano
Russia's First BioPharma Public-Private Partnership Eyes Bio-Betters, Attracts $110 Million
Novartis, AstraZeneca Pledge Support For Russia At St. Petersburg Economic Forum In Latest Big Pharma Move To Go Local
With Nycomed, Takeda Satifies Both Strategic And Financial Objectives
Roche Extends Russian Presence, Inks Second Agreement With ChemRar
Nycomed Expects More Dealmaking in Russia; Prepares Daxas Rollout In Turkey
Russia Pledges $3.9 Billion For Local Pharma Growth, As Big Pharma Scrambles To Set Up Shop
Roche Taps Russian HIV Opportunity With Viriom Deal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV004034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel